PRQR Insider Trading Activity and SEC Form 4 Filings
PRQR insider trading summary
Over the past 12 months, insiders at ProQR Therapeutics N.V. (PRQR) reported 3 open-market purchases worth $850K by 2 insiders and no sales on SEC Form 4. Net insider buying was $850K.
Latest PRQR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Boer Daniel Anton de | Chief Executive Officer | Buy | $354K (200,000 @ $1.77) |
| Jul 17, 2026 | Bart Filius | Director | Buy | $258K (150,000 @ $1.72) |
| Jul 7, 2026 | Boer Daniel Anton de | Chief Executive Officer | Buy | $239K (150,000 @ $1.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.